Go back to the main page.
Transforming Today's Science Into Tomorrow's Cures
Samaritan's collaborative researchers have made important patented discoveries in the fields of, central nervous system diseases, such as, Alzheimer's disease; cancer; cardiovascular disease; and infectious diseases, such as, AIDS, and Hepatitis C. These discoveries have positioned us with a rich pipeline of new drugs with novel mechanisms of actions to develop.
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics. At Samaritan Pharmaceuticals our mission has been to create life-saving drugs for people suffering from AIDS, Alzheimer’s, heart disease and cancer. View all the latest press releases and news articles focused on Samaritan Pharmaceuticals, Inc. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Samaritan has collaborative relationships with other pharmaceutical companies to commercialize branded approved prescription products in selected niche territories, such as, in Greece, Albania, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, FYROM, Hungary, Montenegro, Poland, Romania, Serbia, Slovakia, Slovania, Syria and Turkey. Before a drug can be offered to the public it must go through several phases of rigorous testing to make sure it is safe, efficient and does what it says it can do. The testing is mandated and overseen by the U.S. Food and Drug Administration (FDA) which is part of the U.S. Department of Health and Human Services. SAMARITAN PIPELINE - (MECHANISM OF ACTION VIDEOS)
Go back to the main page. Contact Samaritan Pharmaceuticals, Inc. Find what you are looking for in our website.
Untitled Document
PEER-REVIEWED PUBLICATIONS AND PATENTS
Peer-Reviewed Publications | Patents
Publications refer to scientific papers written about a drug by its creators and published in scientific journals. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Funding agencies use these articles to determine whether or not to fund, and if selected, the amount to fund the research or offer an award.
 

HIV Publications and Abstracts

Publications and Abstracts Product Link
Poster Board Abstract
SP-10
Mechanism of the Inhibition of HIV Entry in MAGI Cells by the Benzamide Derivative SP-10
The Journal of Pharmacology and Experimental Therapeutics, 307:1148–1157, 2003
SP-01A
Inhibition of Adrenal Cortical Steroid Formation by Procaine Is Mediated by Reduction of the cAMP-Induced 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Messenger Ribonucleic Acid Levels
Poster Board Abstract
SP-01A
Procaine Hydrochloride: In Vitro Antiretroviral Properties and Reduction of Viral Load in Patients Using Highly Active Antiretroviral Therapy
Antiviral Chemistry and Chemotherapy. 2006;17(6):331-42
SP-10
The benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl]-4-nitro-benzamide (SP-10) reduces HIV-1 infectivity in vitro by modifying actin dynamics.
Poster Board Abstract
SP-03
Synthesis and characterization of (4-amino-phenyl)-(1-aza-bicyclo[2.2.2]oct-4-yl)-methanone, a quinuclidine derivative with anti-retroviral properties
 
Alzheimer's Disease Publications and Abstracts
Publication and Abstracts Product Link
Neuroscience 148 (2007) 441-453
SP-233
22R-HYDROXYCHOLESTEROL INDUCES DIFFERENTIATION OF HUMAN NT2 PRECURSOR (Ntera2/D1 TERATOCARCINOMA) CELLS
Caprospinol Poster Board Abstract
SP-233
Caprospinol Improves Brain Histopathology and Recovers Memory Function In A Rat Model of Alzheimer's Disease
Steroids, 2006, 725-735
SP-233
Results indicate that Aß1-42 and SP233 exert direct effects on mitochondrial function and SP-233 protects neuronal cells against Aß-induced toxicity by targeting Aß directly.
Chemistry & Biodiversity, Vol. 2 (2005) 1571
SP-233
Methodology for Multi-Site Ligand - Protein Docking Identification Developed for the Optimization of Spirostenol Inhibition of ß-Amyloid-Induced Neurotoxicity
Steroids, 2004 69(1):1-16
SP-233
Identification of naturally occurring spirostenols preventing beta-amyloid-induced neurotoxicity
Poster Board Abstract
SP-233
Naturally occuring 22R-Hydroxycholesterol Derivatives Project Neuronal Cells Against ß-Amyloid (1-42) Toxicity
Poster Board Abstract
SP-233
The spirostenol (22S,25S)-(20S)-spirost-5-en-3ß-yl hexanoate prevents Aß-induced impairment of mitochondrial function and blacks mitochondrial AB uptake into neuronal cells
J Neurochem, 2002, 83, 1110-1119
SP-233
22R-Hydroxycholesterol Protects Neuronal Cells from B-Amyloid-Induced Cytotoxicity by Binding to ß-Amyloid Peptide
Poster Board Abstract
SP-04
In vitro and in vivo characterization of a novel acetylcholinesterase inhibitor, dimethyl-carbamic 2, 3-bis-dimethylcarbamoyloxy-6-[4-(4-thyl-piperazin-1-yl)-butyryl]-phenyl ester
Bioorganic & Medicinal Chemistry Letters 16 (2006) 62777-6280
SP-04
Three-dimensional quantitative structure-activity relationship (3D QSAR) of acetylcholinesterase (AChE) inhibitors, based on molecular docking scores and comparative molecular field analysis (CoMFA)
Neuropharmacology, 49 (2005): 86-96
SP-08
Identification, design, synthesis, and pharmacological activity of (4-ethyl-piperazin-1-yl)-phenylmethanone derivatives with neuroprotective properties against ß-amyloid-induced toxicity
Pharmacology, 2005;74:65-78
SP-08
Local Anesthetic Procaine Protects Rat Pheochromocytoma PC12 Cells against ß-Amyloid-Induced Neurotoxicity
Poster Board Abstract
SP-sc7
A steroid naturally occuring in the soft water fungi Achlya heterosexualis induces neurogenesis in vitro and in vivo in rat brain
Analytical Biochem, 2004 324(1):123-30
AD Diagnostic
A Capillary Gas Chromatography/Mass Spectrometric Method for The Quantification of Hydroxysteroids in Human Plasma
Neurobiology of Aging, 24 (2003) 57-65
AD Diagnostic
Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology
Pharmacology, 2006;76:19–33
AD Rat Model
Beta-Amyloid and Oxidative Stress Jointly Induce Neuronal Death, Amyloid Deposits, Gliosis, and Memory Impairment in the Rat Brain
 
Cancer Publications and Abstracts
Publication and Abstracts Product Link
J Recept Signal Transduct Res, 2003;23(2-3):225-38.
BC Diagnostic
Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression
Molecular Endocrinology15(12):2211-2228
BC Diagnostic
Identification, Localization, and Function in Steroidogenesis of PAP7: A Peripheral-Type
Benzodiazepine Receptor- and PKA (RI)- Associated Protein
Cancer Re,. 1999 Feb 15;59(4):831-42
BC Diagnostic
Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol
 
Cardiovascular Disease Publications and Abstracts
Publication and Abstracts Product Link
Poster Board Abstract
SP-1000
Control of hypercholesterolemia and atherosclerosis using a peptide containing the cholesterol recognition/interaction amino acid consensus VLNYYVWR
Mol Endocrinology, 19 (3): 588-594 (2004)
SP-1000
Characterization of the Cholesterol Recognition Amino Acid Consensus Sequence of the Peripheral-type Benzodiazepine Receptor
Biochemical and Biophysical Res. Comm, 284, 536-541 (2001)
SP-1000
Structural and Functional Study of Reconstituted Peripheral Benzodiazepine Receptor
PNAS,. Jan 30, 2001. Vol 98. No. 3. 1267 - 1272.
SP-1000
Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibitor of steroidogenesis by an HIV-TAT-CRAC peptide
Endocrinology, 1998
Dec;139(12):4991-7
SP-1000
Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern